PINK:RAFA

Rafarma Pharmaceuticals Stock Forecast

etoro logo Buy RAFA
*Your capital is at risk
$0.0400
+0 (+0%)
At Close: Jun 16, 2026
AI Analysis AI Analysis of RAFA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RAFA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Rafarma Pharmaceuticals, Inc. stock upgraded from Sell Candidate to Hold/Accumulate after Tuesday trading session
(Updated on Jun 16, 2026)

Hold candidate since Jun 16, 2026

No changes to the price of Rafarma Pharmaceuticals, Inc. stock on the last trading day (Tuesday, 16th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0400 to a day high of $0.0400. The price has been going up and down for this period, and there has been a -33.33% loss for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.47% during the next 3 months and, with a 90% probability hold a price between $0.0164 and $0.0434 at the end of this 3-month period.

RAFA Signals & Forecast

There are mixed signals in the stock today. The Rafarma Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0517. On a fall, the stock will find some support from the short-term average at $0.0384. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, June 15, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rafarma Pharmaceuticals, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0350 and $0.0340. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.0340 may give a huge drop in the stock price.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.0382 (-4.40%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (RAFA) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Rafarma Pharmaceuticals, Inc. to open at $0.0400, and during the day (based on 14 day Average True Range), to move between $0.0377 and $0.0423, which gives a possible trading interval of +/-$0.0045 (+/-12.00%) up or down from last closing price. If Rafarma Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 12.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0440 (10.00%) than the support at $0.0350 (12.50%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rafarma Pharmaceuticals, Inc. stock A Buy?

Rafarma Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $0.0400 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RAFA Performance

Trading levels for RAFA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0400 -
R2 0.0400 -
R1 0.0400 -
Price 0.0400
S1 0.0400 -
S2 0.0400 -
S3 0.0400 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0.0441 10.20%
R1 0.0440 10.00%
Price 0.0400
S1 0.0350 -12.50%
S2 0.0340 -15.00%
S3 0 -

FAQ

What is the symbol for Rafarma Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Rafarma Pharmaceuticals, Inc. is RAFA and it is traded on the PINK (Pink Sheets).

Should I buy or sell Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Rafarma Pharmaceuticals, Inc. Stock?
Rafarma Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rafarma Pharmaceuticals, Inc. Stock.

What's the current price of Rafarma Pharmaceuticals, Inc. Stock?
As of the end of day on the Jun 16, 2026, the price of an Rafarma Pharmaceuticals, Inc. (RAFA) share was $0.0400.

What is the 52-week high and low for Rafarma Pharmaceuticals, Inc. Stock?
The 52-week high for Rafarma Pharmaceuticals, Inc. Stock is $0.0985 and the 52-week low is $0.0036.

What is the market capitalization of Rafarma Pharmaceuticals, Inc. Stock?
As of the Jun 16, 2026, the market capitalization of Rafarma Pharmaceuticals, Inc. is 4.476M.
Click to get the best stock tips daily for free!
ABOUT RAFARMA PHARMACEUTICALS, INC.
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
5.49% Jun 12
GIB
$66.69
0.225% Jun 12
EAT
$140.46
9.32% Jun 05
TPR
$140.47
6.35% Jun 04
GLBE
$31.61
2.12% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE